Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Discovery of MCM2-7 complex is new therapeutic target for neuroendocrine prostate cancer

June 25, 2021

Exiting new study from our lab identifies MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer. Congratulations En-chi and team!

https://www.nature.com/articles/s41598-021-92552-x

June 25, 2021

NewsStanford

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousExciting news: Dr. Busola Alabi joins Stoyanova lab!

  • NextDevelopment of a new method for the quantification of cancer invasion and migration ability

Related Posts ...

Exciting News: Dr. Stoyanova is promoted to a Full Professor at the University of California, Los Angeles

News, UCLA
Reva Patel

Congratulations on the Great Achievement, Reva! Reva Patel Receives Dean’s Prize for Excellence in Science at the Undergraduate Research and Creativity Showcase

News

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login